Quince Therapeutics Inc. (NASDAQ: QNCX) closed the day trading at $0.73 down -0.01% from the previous closing price of $0.73. In other words, the price has decreased by -$0.0001 from its previous closing price. On the day, 204082 shares were traded.
For a better understanding of QNCX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.90 and its Current Ratio is at 19.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
Stock Price History:
Over the past 52 weeks, QNCX has reached a high of $14.69, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is 1.0719, while the 200-Day Moving Average is calculated to be 2.8420.
Over the past 3-months, QNCX traded about 223.65K shares per day on average, while over the past 10 days, QNCX traded about 339.23k shares per day. A total of 35.61M shares are outstanding, with a floating share count of 27.29M. Insiders hold about 4.50% of the company’s shares, while institutions hold 25.50% stake in the company. Shares short for QNCX as of Oct 13, 2022 were 3.53M with a Short Ratio of 3.62M, compared to 3.56M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 9.77% and a Short% of Float of 13.86%.
Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of -$0.28 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.28, while EPS last year was -$0.73. The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.29 and low estimates of -$0.29.
Analysts are recommending an EPS of between -$1.57 and -$1.57 for the fiscal current year, implying an average EPS of -$1.57. EPS for the following year is -$1.33, with 1 analysts recommending between -$1.33 and -$1.33.